At close: December 20 at 4:00:02 PM EST
Pre-Market: 7:35:58 AM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
5,189.9180
1,892.1830
666.2500
Total Liabilities Net Minority Interest
1,362.8420
760.8730
215.6220
Total Equity Gross Minority Interest
3,827.0760
1,131.3100
450.6280
Total Capitalization
3,827.0760
1,131.3100
450.6280
Preferred Stock Equity
--
0.5710
0.3850
Common Stock Equity
3,827.0760
1,130.7390
450.2430
Capital Lease Obligations
210.4890
283.2170
--
Net Tangible Assets
3,827.0760
1,131.3100
450.6280
Working Capital
3,622.0910
963.0500
420.9030
Invested Capital
3,827.0760
1,130.7390
450.2430
Tangible Book Value
3,827.0760
1,130.7390
450.2430
Total Debt
210.4890
283.2170
--
Share Issued
17,329.6150
17,329.6150
17,329.6150
Ordinary Shares Number
17,329.6150
17,329.6150
17,329.6150
12/31/2021 - 11/21/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PBM Psyence Biomedical Ltd.
3.1800
+29.27%
BPTH Bio-Path Holdings, Inc.
1.2600
-15.44%
CERO CERo Therapeutics Holdings, Inc.
0.0561
+3.89%
CGTX Cognition Therapeutics, Inc.
0.6301
-0.62%
APTO Aptose Biosciences Inc.
0.2790
+63.92%
PRTG Portage Biotech Inc.
5.96
+1.88%
PLRZ Polyrizon Ltd.
1.5700
-32.62%
ABP Abpro Corporation
2.0700
+38.93%
SLXN Silexion Therapeutics Corp
2.4400
+0.83%
OGEN Oragenics, Inc.
0.3552
-5.53%